M. A. Baker
About
In The Last Decade
M. A. Baker
18 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Biology 699
- Oncology 399
- Immunology 250
- Hematology 247
- Surgery 222
Countries citing papers authored by M. A. Baker
This map shows the geographic impact of M. A. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Baker more than expected).
Fields of papers citing papers by M. A. Baker
This network shows the impact of papers produced by M. A. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Baker. The network helps show where M. A. Baker may publish in the future.
Co-authorship network of co-authors of M. A. Baker
This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Baker. A scholar is included among the top collaborators of M. A. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Baker. M. A. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 105 | |
| 2 | 7 | |
| 3 | 2 | |
| 4 | Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. | 151 |
| 5 | 63 | |
| 6 | Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells. | 75 |
| 7 | Human leukemic myeloblasts and myeloblastoid cells contain the enzyme cytidine 5'-monophosphate-N-acetylneuraminic acid:Gal beta 1-3GalNAc alpha (2-3)-sialyltransferase. | 11 |
| 8 | Expression of the CD34 gene in vascular endothelial cells breakdown → | 746 |
| 9 | 57 | |
| 10 | Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. | 88 |
| 11 | 62 | |
| 12 | Structural and partial amino acid sequence analysis of the human hemopoietic progenitor cell antigen CD34. | 68 |
| 13 | Presence of cytidine 5'-monophospho-N-acetylneuraminic acid:Gal beta 1-3GalNAc-R alpha(2-3)-sialyltransferase in normal human leukocytes and increased activity of this enzyme in granulocytes from chronic myelogenous leukemia patients. | 13 |
| 14 | 6 | |
| 15 | 31 | |
| 16 | Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus. | 8 |
| 17 | 24 | |
| 18 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.